

Today, Explained
Vox
Today, Explained is Vox's daily news explainer podcast. Hosts Sean Rameswaram and Noel King will guide you through the most important stories of the day.Part of the Vox Media Podcast Network.
Episodes
Mentioned books

9 snips
Aug 14, 2024 • 25min
So you toppled an autocrat
Redwan Ahmed, a freelance journalist from Dhaka, dives into Bangladesh's turbulent political scene. He explores the potential of a Nobel laureate stepping in as prime minister, contrasting the legacy of Sheikh Hasina's leadership. The conversation touches on the impact of microfinance on women's empowerment, while also highlighting the pressing challenges of an interim government. With escalating protests for reform, Ahmed provides insights on the delicate balance needed for a successful political transition in a nation seeking democracy.

12 snips
Aug 13, 2024 • 26min
The tech titans backing Trump
Emily Glazer, a reporter at The Wall Street Journal, dives into the intriguing shift in Silicon Valley's political loyalties. She discusses how tech titans like Elon Musk are now backing Donald Trump, challenging the traditional Democratic support. The conversation explores the impact of financial power on politics and the implications for governance as tech leaders seek deregulation in key sectors. Glazer also highlights Kamala Harris's robust ties to the tech community and the expectations for policy changes surrounding immigration and AI.

54 snips
Aug 12, 2024 • 26min
ClassGPT
Olivia Stowell, a PhD candidate in media studies, and Antonio Byrd, an English professor, tackle the heated debate on AI tools in education. Stowell discusses how generative AI can empower students, while Byrd emphasizes the need for responsible integration and clear writing standards. They explore the ethical dilemmas of AI's impact on academic integrity and the diverse institutional policies shaping its use. Both urge a balance that allows students to harness AI for creativity without sacrificing academic honesty.

22 snips
Aug 9, 2024 • 27min
A green medal for Paris?
Mary Winston Nicklin, a National Geographic contributor and expert on the Seine River, joins Madeline Orr, a sport ecology professor, to discuss Paris’s ambitious plans for the greenest Olympics ever. They explore the $1.5 billion cleanup of the Seine, transforming it from a polluted waterway to a thriving ecosystem. The conversation also dives into the challenges of hosting sustainable games amid concerns about extreme heat and the practicality of their eco-friendly initiatives, raising questions about tourism's burden on local environments.

Aug 8, 2024 • 27min
Ecstasy Therapy: Bad trip
Sarah McNamee, a participant in a clinical trial for MDMA-assisted therapy, candidly shares her challenging experience, highlighting the gap between expectations and reality. She explores the emotional complexities of her journey with PTSD and the controversial aftermath of the therapy. The conversation raises critical questions about participant well-being, the ethical considerations of clinical trials, and the potential risks of MDMA therapy, revealing a nuanced perspective on mental health recovery amid the excitement over psychedelic treatments.

14 snips
Aug 7, 2024 • 26min
Riots in the UK
Robyn Vinter, North of England correspondent at The Guardian, delves into the chaos erupting across the UK following a tragic knife attack. She discusses the emotional aftermath in Southport, where a violent incident at a dance class left children injured. Vinter highlights the unsettling role of misinformation in igniting protests and the rising anti-immigration sentiments fueling unrest. The podcast also examines the complex dynamics behind the riots, including community tensions and social media’s influence on public sentiment and responses.

5 snips
Aug 6, 2024 • 26min
It's Tim Walz
Dana Ferguson, senior political reporter at Minnesota Public Radio, and Andrew Prokop, Vox journalist, dive into the political landscape following Tim Walz's rise as a vice-presidential contender. They discuss his journey from teacher to governor, his evolving stance on gun control, and unique strategies like branding opponents as 'weird.' The conversation also highlights the importance of engaging campaigning styles, especially in swing states, and analyzes the implications of Kamala Harris's ticket choices for future elections.

10 snips
Aug 5, 2024 • 26min
RIP Project 2025?
Join Shelby Talcott, a savvy politics reporter from Semafor, and Eli Stokols, an astute White House correspondent for Politico, as they dive into the controversial Project 2025. They dissect how fringe policies are reshaping the presidential landscape and raising eyebrows among voters. The duo explores the Democrats' strategy of branding their opponents as 'weird' and the implications of this messaging. With insights on political rhetoric and voter engagement, they shed light on how terms and narratives can influence the upcoming election.

22 snips
Aug 2, 2024 • 28min
Ecstasy Therapy: How MDMA became medicine
Haleema Shah, a reporter and producer focusing on MDMA therapy for PTSD, dives into the groundbreaking transformation of MDMA from a stigmatized substance to a potential healing tool. The discussion highlights military veterans' struggles with PTSD and their unlikely collaboration with the psychedelic movement. Personal stories from veterans on their journeys through MDMA-assisted therapy showcase its potential as a revolutionary treatment. The podcast also navigates the challenges of gaining FDA approval and changing societal attitudes toward psychedelics.

8 snips
Aug 1, 2024 • 28min
Ecstasy Therapy: Penicillin for the soul
Haleema Shah, a reporter and producer focused on the therapeutic uses of MDMA, delves into the fascinating history of this psychedelic. She discusses the pioneering work of an eccentric chemist in the '80s, highlighting MDMA's journey from a therapeutic tool to a recreational drug. Listeners will learn about its potential in treating PTSD, the obstacles faced by researchers, and personal stories of transformation. The podcast also touches on the current evaluation by the FDA, marking a crucial moment for the future of psychedelic therapy.


